Urology Noticias Destacadas Feb. 05, 2021 Hydronephrosis and bladder cancer Retrospective research does not support an increased risk of upper tract urothelial carcinoma (UTUC) in patients receiving preoperative ureteral stenting for hydronephrosis requiring drainage prior to cystectomy. Nov. 20, 2020 Men's Health moves many operative procedures into the office Mayo Clinic's Men's Health specialists now perform testicular sperm extraction, circumcision, scrotoplasty, orchiopexy, hydrocelectomy, and spermatocelectomy or epididymal cyst excision and epididymectomy in-office, with minimal patient sedation. Feb. 05, 2021 High-risk nonmuscle invasive bladder cancer In a phase III clinical trial, 53% of patients with nonmuscle invasive bladder cancer (NMIBC) in the carcinoma in situ cohort had a complete response within three months of treatment. Feb. 05, 2021 Ureteral injury malpractice compensation highest in cases of patient-perceived delays, inadequate workup and failure of supervision Multiple studies suggest that iatrogenic ureteral injuries, while uncommon, make up a disproportionate number of litigation claims. Gynecology and urology are the specialties most commonly named. Current therapies for patients with overactive bladder Overactive bladder and its symptoms can be discouraging and debilitating for patients. Making use of the most current therapies and implementing them in a prescribed sequence, starting with the most conservative measures, is the key to managing the problem. Newly discovered autoimmune disease associated with testicular cancer Sean J. Pittock, M.D., an autoimmune neurologist at Mayo Clinic, discusses a newly discovered autoimmune disease that appears to affect men with testicular cancer. A multidisciplinary approach to genitourinary cancers Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer. Publications E-NEWSLETTER EDITION See the latest edition plus past issues 1 Study assesses cost-effectiveness of pembrolizumab for treatment of bacillus Calmette-Guerin-unresponsive bladder carcinoma in situ 2 National patterns of filled prescriptions and third line treatment use for privately insured women with overactive bladder 3 Development of urosymphyseal fistula in posterior urethral stenosis 4 COVID-19 adjustments impact Urology Residency training 5 Therapeutic sequencing improves outcomes for patients with progressive mCRPC Profesionales médicos Urology